Forschungsprojekte
Ergebnisse pro Seite:
10
2022 - 2025
(Wieder-) Herstellung der Tumorimmunität im Pankreaskarzinom und Karzinomen des oberen Gastrointestinaltraktes- Univ.-Prof. Dr. MatthiasGaida
2022 - 2025
Integrierte OMICS, Bioinformatik und Morpho-molekulare Immunomonitoring Plattform- Univ.-Prof. Dr. MatthiasGaida,
- Univ.-Prof. Dr. StefanTenzer,
- Dr. ValescaBukur
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. MaximilianBrandt,
- PD Dr. ReneMager,
- Dr. AnitaThomas
2022 - 2026
Verbund PEARL - Prävention von Darmkrebs im jungen und mittleren Erwachsenenalter- Univ.-Prof. Dr. WilfriedRoth
2021 - 2023
Utilization of the HLA-independent anti-tumor T-cell repertoire for cancer immuno therapy- Univ.-Prof. Dr. MatthiasGaida,
- Univ.-Prof. Dr. ThomasWölfel,
- Univ.-Prof. Dr. SvenDanckwardt,
- Dr. HakimEchchannaoui
2021 - 2023
To enhance anti-tumor immune responses by inhibiting a pair of immune checkpoints- Univ.-Prof. Dr. MatthiasGaida,
- Dr. SebastianKreiter
2021 - 2023
Evaluation of the effects of BMP/ACVRI signaling pathway in cancer cells on T cell mediated therapeutic outcome upon checkpoint inhibitor treatment using murine and human tumor models- Univ.-Prof. Dr. MatthiasGaida,
- Dr. FulviaVascotto
2021 - 2024
Exploiting liquid biopsies to advance cancer precision medicine (ExLiquid)- Dr. NilsHartmann,
- Dr. AlexanderDesuki
2021 - 2026
A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN-MCL-321) (#1349)- Prof. Dr. med. GeorgHeß,
- Marie-KristinTilch
2021 - 2022
Deutsches Register von COVID-19 Obduzierten Fällen {DeRegCOVID)- Univ.-Prof. Dr. WilfriedRoth